Hong Kong biotech start-up Alephoson eyes global trial for eye-drug delivery
- Posted on February 10, 2025
- By South China Morning Post
- 2 Views
![](https://cdn.i-scmp.com/sites/default/files/styles/og_image_scmp_generic/public/d8/images/canvas/2025/02/09/8c77aa9b-f85b-4f38-a16b-4732104605a7_7236fe8b.jpg?itok=mS7XVnEW&v=1739102400)
Hong Kong biotech start-up Alephoson eyes global trial for eye-drug delivery
![](https://cdn.i-scmp.com/sites/default/files/styles/og_image_scmp_generic/public/d8/images/canvas/2025/02/09/8c77aa9b-f85b-4f38-a16b-4732104605a7_7236fe8b.jpg?itok=mS7XVnEW&v=1739102400)
Hong Kong biotech start-up works with university partners to conduct global clinical trials studying prevalent eye diseases.